Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Cash & Equivalents: 2018-2025

Historic Cash & Equivalents for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $43.5 million.

  • Evolus' Cash & Equivalents fell 48.82% to $43.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.5 million, marking a year-over-year decrease of 48.82%. This contributed to the annual value of $87.0 million for FY2024, which is 38.37% up from last year.
  • Evolus' Cash & Equivalents amounted to $43.5 million in Q3 2025, which was down 29.50% from $61.7 million recorded in Q2 2025.
  • Over the past 5 years, Evolus' Cash & Equivalents peaked at $146.3 million during Q4 2021, and registered a low of $22.2 million during Q1 2021.
  • In the last 3 years, Evolus' Cash & Equivalents had a median value of $62.8 million in 2023 and averaged $64.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 381.13% in 2022, then tumbled by 70.50% in 2023.
  • Quarterly analysis of 5 years shows Evolus' Cash & Equivalents stood at $146.3 million in 2021, then plummeted by 63.13% to $53.9 million in 2022, then increased by 16.53% to $62.8 million in 2023, then surged by 38.37% to $87.0 million in 2024, then slumped by 48.82% to $43.5 million in 2025.
  • Its Cash & Equivalents was $43.5 million in Q3 2025, compared to $61.7 million in Q2 2025 and $67.9 million in Q1 2025.